AIF3 splicing switch triggers neurodegeneration

[1]  C. Brenner,et al.  AIF meets the CHCHD4/Mia40-dependent mitochondrial import pathway. , 2020, Biochimica et Biophysica Acta - Molecular Basis of Disease.

[2]  P. Nicotera,et al.  A disease-associated Aifm1 variant induces severe myopathy in knockin mice , 2018, Molecular metabolism.

[3]  J. Prehn,et al.  Apoptosis-Inducing Factor (AIF) in Physiology and Disease: The Tale of a Repented Natural Born Killer , 2018, EBioMedicine.

[4]  Publisher's Note , 2018, Anaesthesia.

[5]  R. Dortch,et al.  A novel missense mutation in AIFM1 results in axonal polyneuropathy and misassembly of OXPHOS complexes , 2017, European journal of neurology.

[6]  C. Marco-Marín,et al.  A newly distal hereditary motor neuropathy caused by a rare AIFM1 mutation , 2017, neurogenetics.

[7]  S. Humphray,et al.  X-linked hypomyelination with spondylometaphyseal dysplasia (H-SMD) associated with mutations in AIFM1 , 2017, neurogenetics.

[8]  Sanjay P. Prabhu,et al.  AIFM1 mutation presenting with fatal encephalomyopathy and mitochondrial disease in an infant , 2017, Cold Spring Harbor molecular case studies.

[9]  Deborah A. Levine,et al.  Post-stroke dementia – a comprehensive review , 2017, BMC Medicine.

[10]  E. Obersztyn,et al.  Spondyloepimetaphyseal dysplasia with neurodegeneration associated with AIFM1 mutation – a novel phenotype of the mitochondrial disease , 2017, Clinical genetics.

[11]  J. Qian,et al.  A nuclease that mediates cell death induced by DNA damage and poly(ADP-ribose) polymerase-1 , 2016, Science.

[12]  I. Sevrioukova.  Structure/Function Relations in AIFM1 Variants Associated with Neurodegenerative Disorders. , 2016, Journal of molecular biology.

[13]  Rufus Akinyemi,et al.  Stroke injury, cognitive impairment and vascular dementia , 2016, Biochimica et biophysica acta.

[14]  E. Bertini,et al.  A novel AIFM1 mutation expands the phenotype to an infantile motor neuron disease , 2015, European Journal of Human Genetics.

[15]  Elena Vecino,et al.  Glia–neuron interactions in the mammalian retina , 2016, Progress in Retinal and Eye Research.

[16]  K. Rajewsky,et al.  Efficient generation of Rosa26 knock-in mice using CRISPR/Cas9 in C57BL/6 zygotes , 2016, BMC Biotechnology.

[17]  E. Lamantea,et al.  A slowly progressive mitochondrial encephalomyopathy widens the spectrum of AIFM1 disorders , 2015, Neurology.

[18]  P. Huppke,et al.  From ventriculomegaly to severe muscular atrophy: expansion of the clinical spectrum related to mutations in AIFM1. , 2015, Mitochondrion.

[19]  D. Lowy,et al.  Isolation of Mouse Embryo Fibroblasts. , 2013, Bio-protocol.

[20]  M. Hegde,et al.  Mitochondrial dysfunction in psychiatric and neurological diseases: Cause(s), consequence(s), and implications of antioxidant therapy , 2013, BioFactors.

[21]  Qian-Quan Sun,et al.  Distribution of CaMKIIα expression in the brain in vivo, studied by CaMKIIα-GFP mice , 2013, Brain Research.

[22]  K. Fischbeck,et al.  Cowchock syndrome is associated with a mutation in apoptosis-inducing factor. , 2012, American journal of human genetics.

[23]  T. Dawson,et al.  Poly(ADP-Ribose) (PAR) Binding to Apoptosis-Inducing Factor Is Critical for PAR Polymerase-1–Dependent Cell Death (Parthanatos) , 2011, Science Signaling.

[24]  K. Sakata,et al.  Lack of promoter IV‐driven BDNF transcription results in depression‐like behavior , 2010, Genes, brain, and behavior.

[25]  Severe X-linked mitochondrial encephalomyopathy associated with a mutation in apoptosis-inducing factor. , 2010, American journal of human genetics.

[26]  P. Bénit,et al.  A brain-specific isoform of mitochondrial apoptosis-inducing factor: AIF2 , 2010, Cell Death and Differentiation.

[27]  O. Ottersen,et al.  Outer mitochondrial membrane localization of apoptosis-inducing factor: mechanistic implications for release , 2009, ASN neuro.

[28]  T. Dawson,et al.  Poly(ADP-ribose) signals to mitochondrial AIF: A key event in parthanatos , 2009, Experimental Neurology.

[29]  P. Bénit,et al.  The Variability of the Harlequin Mouse Phenotype Resembles that of Human Mitochondrial-Complex I-Deficiency Syndromes , 2008, PloS one.

[30]  S. Ackerman,et al.  Loss of Apoptosis-Inducing Factor Results in Cell-Type-Specific Neurogenesis Defects , 2008, The Journal of Neuroscience.

[31]  P. Bénit,et al.  Targeted Deletion of AIF Decreases Mitochondrial Oxidative Phosphorylation and Protects from Obesity and Diabetes , 2007, Cell.

[32]  David S. Park,et al.  Dissociating the dual roles of apoptosis‐inducing factor in maintaining mitochondrial structure and apoptosis , 2006, The EMBO journal.

[33]  V. Yuste,et al.  Identification and Characterization of AIFsh2, a Mitochondrial Apoptosis-inducing Factor (AIF) Isoform with NADH Oxidase Activity* , 2006, Journal of Biological Chemistry.

[34]  J. Bellalou,et al.  AIFsh, a Novel Apoptosis-inducing Factor (AIF) Pro-apoptotic Isoform with Potential Pathological Relevance in Human Cancer* , 2006, Journal of Biological Chemistry.

[35]  P. Bénit,et al.  Muscle-Specific Loss of Apoptosis-Inducing Factor Leads to Mitochondrial Dysfunction, Skeletal Muscle Atrophy, and Dilated Cardiomyopathy , 2005, Molecular and Cellular Biology.

[36]  T. Dawson,et al.  Bcl-x Is Required for Proper Development of the Mouse Substantia Nigra , 2005, The Journal of Neuroscience.

[37]  K. Mihara,et al.  Export of mitochondrial AIF in response to proapoptotic stimuli depends on processing at the intermembrane space , 2005, The EMBO journal.

[38]  P. Bénit,et al.  AIF deficiency compromises oxidative phosphorylation , 2004, The EMBO journal.

[39]  Wayne N. Frankel,et al.  The harlequin mouse mutation downregulates apoptosis-inducing factor , 2002, Nature.

[40]  G. Kroemer,et al.  DNA binding is required for the apoptogenic action of apoptosis inducing factor , 2002, Nature Structural Biology.

[41]  T. Dawson,et al.  Mediation of Poly(ADP-Ribose) Polymerase-1-Dependent Cell Death by Apoptosis-Inducing Factor , 2002, Science.

[42]  Ahmed Haouz,et al.  The crystal structure of the mouse apoptosis-inducing factor AIF , 2002, Nature Structural Biology.

[43]  T. Lemberger,et al.  A CamKIIα iCre BAC allows brain‐specific gene inactivation , 2001 .

[44]  G. Kroemer,et al.  NADH Oxidase Activity of Mitochondrial Apoptosis-inducing Factor* , 2001, The Journal of Biological Chemistry.

[45]  T. Lemberger,et al.  A CamKIIalpha iCre BAC allows brain-specific gene inactivation. , 2001, Genesis.

[46]  S. Zeitlin,et al.  CaMKIIalpha-Cre transgene expression and recombination patterns in the mouse brain. , 2000, Genesis.

[47]  Ruedi Aebersold,et al.  Molecular characterization of mitochondrial apoptosis-inducing factor , 1999, Nature.

[48]  J. McCaffery,et al.  Localization of GTPases by indirect immunofluorescence and immunoelectron microscopy. , 1995, Methods in enzymology.

[49]  T. Dawson,et al.  Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.